IPWatchdog’s most recent webinar focused on the role of IP in the development of the most promising vaccines to combat COVID-19 and included speakers from the medical community, the U.S. Food and Drug Administration (FDA) and the biopharmaceutical industry. The upshot was: wear masks, get the Read More>>
Categories Government, Interviews & Conversations, IP News, IPWatchdog Articles, Patents, astrazeneca, bio, coronavirus, COVID-19, Food and Drug Administration, intellectual property, IPWatchdog Webinars, Moderna, patent, Pfizer, vaccines
